Reducing the global burden of disease in childhood - Authors' reply.

Vogel JP, Chawanpaiboon S, Gülmezoglu AM, study authors

Caring for the carers: Ensuring the provision of quality maternity care during a global pandemic.

Wilson AN, Ravaldi C, Scoullar MJL, Vogel JP, Szabo RA, Fisher JRW, Homer CSE

COVID-19 Maternal, Newborn + Child Health

An evaluation of the benefits and harms of antenatal corticosteroid treatment for women at risk of imminent preterm birth or prior to elective Caesarean-section: Study protocol for an individual participant data meta-analysis.

Wastnedge E, Vogel J, Been JV, Bannerman-Gyamfi C, Schuit E, Roberts D, Reynolds RM, Stock S, Co_Opt collaboration

The World Health Organization ACTION-I (Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns) Trial: a multi-country, multi-centre, two-arm, parallel, double-blind, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at risk of imminent birth in the early preterm period in hospitals in low-resource countries.

WHO ACTION Trials Collaborators

Pregnancy outcomes of women with previous caesarean sections: Secondary analysis of World Health Organization Multicountry Survey on Maternal and Newborn Health.

Kietpeerakool C, Lumbiganon P, Laopaiboon M, Rattanakanokchai S, Vogel JP, Gülmezoglu AM

Gender balance in WHO panels for guidelines published from 2008 to 2018.

Bohren MA, Javadi D, Vogel JP